Given their significance in cancer immunology, these interactions encompass receptor-ligand interactions from various families, such as the Wnt signaling pathway and pluripotency, the transcriptional targets of the Kit receptor, the regulation of interleukin-3, and signaling events mediated by the stem cell factor receptor (c-Kit). The gene discussed is KIT; the disease is cancer.